Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Yes great opportunity for those who got in at the bottom as I personally doubt we’ll see those numbers again. Also nice to see new faces and some diamond hands. There is a telegram group that it would be great if you joined, just go on Twitter, search #genf and you’ll find the link there :)
Seems Eli Lilly are busy buying up readily established production plants for self administration injectables.
I would like to see SIRT6 being manufactured and available to the public to help boost their longevity via self injectables. It seems there are a diverse range of health benefits, not just for the liver!
https://www.biopharmadive.com/news/eli-lilly-nexus-manufacturing-factory-acquire/713897/
From what I’ve seen, the company have only started to make progress since Swann started buying up. Before that it was a failed exploration company and at risk of being another Love Hemp. The company has done a good job over the years taking shareholder funds, funding fat cat board salaries and not really delivering much else. It’s all good having patents and having lots of contracts, but if the company isn’t making money and keeps eating shareholder funds what’s the point. Best to chop the dead wood now before things really take off and let the professionals step in. The company now has a real shot at success with the right people around who aren’t self serving. In my humble opinion…
Interview with Zak Mir:
https://m.youtube.com/watch?v=FJOC1ciauAg
- US fast tracking Nash trials
- 100,000 patients on liver transplant list in US alone
- talk of further US institutions coming in
- delivering Nash treatment like a vaccination - think how much money was made on covid…